跳至主要内容
临床试验/NCT07237022
NCT07237022招募中不适用

The Role of Transient Receptor Potential Channels in Diabetic Peripheral Neuropathy

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年10月8日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Dermal Blood Flow response (PU)

研究概览

简要总结

The study aims to characterize the vascular response upon topical application of cinnamaldehyde, allyl isothiocyanate and capsaicin on feet skin in healthy volunteers. The vascular response will be characterized in terms of response over time, dose-response, inter-foot and inter-period reproducibility.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is a white male or female ≥18 and ≤45 years of age
  • Subject is a non-smoker for at least 6 months prior to the start of the study
  • Subject has a body mass index (BMI) between 18-30 kg/m²
  • Subject is judged to be in good general health on the basis of medical history, physical examination and vital signs
  • Subject understands the procedures and agrees to participate in the study by giving written informed consent.

排除标准

  • Subject has a history of any illness or disorder which, in the investigator's opinion, might confound the results of the study
  • Subject has a history of significant severe (drug) allergies
  • Subject is a female who is pregnant, breast-feeding or intends to become pregnant, or is of child-bearing potential and is not using an adequate contraceptive method
  • Subject uses any prescription or non-prescription drugs on a regular basis which, in the investigator's opinion, might confound the results of the study
  • Subject currently uses lotions, oils, depilatory preparations, makeup, or other topical treatments on the feet on a regular basis which cannot be discontinued for the duration of the study
  • Subject has eczema, scleroderma, psoriasis, dermatitis or keloids, tumors, ulcers, burns, skin flaps or grafts on the volar surface of the forearm or the dorsum of the feet, or any other skin abnormality that, in the opinion of the investigator, may interfere with the study assessments
  • Subject has excessive hair growth on the volar surface of the forearms or the dorsum of the feet
  • Subject has any of the following vital sign measurements at screening after at least 10 minutes of supine rest: Heart Rate <40 or >100 beats/min, Diastolic Blood Pressure <50 or >90 mmHg, Systolic Blood Pressure <90 or >140 mmHg
  • Subject is unable to refrain from drinking caffeinated beverages (e.g. coffee, tea, cola, …) 24 hours prior to each study visit. Subject is unable to limit their intake of caffeinated beverages to ≤4 cups a day throughout the study
  • Subject is unable to refrain from drinking alcohol 24 hours prior to each study visit, is currently a regular user of illegal drugs, or has a history of substance abuse (including alcohol)
  • Subject is currently participating or has been involved in testing an investigational drug in another clinical study within the last 4 weeks
  • Subject is in a situation or has a condition which, in the opinion of the investigator, may interfere with safe and optimal participation in the study

结局指标

主要结局

Dermal Blood Flow response (PU)

时间窗: Up until 60 minutes after cinnamaldehyde and AITC application; and up until 90 minutes after capsaicin application.

The DBF response prior to and at each point in time after topical application of cinnamaldehyde, AITC and capsaicin on the foot, assessed with LSCI, within the area of application, expressed in arbitrary perfusion units (PU).

Flare area (mm²)

时间窗: Up until 60 minutes after cinnamaldehyde and AITC application; and up until 90 minutes after capsaicin application.

The flare area of the DBF response prior to and at each point in time after topical application of cinnamaldehyde, AITC and capsaicin on the feet, assessed with LSCI.

次要结局

  • Numeric Rating Scale (NRS) pain score(Up until 60 minutes after cinnamaldehyde and AITC application; and up until 90 minutes after capsaicin application.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Role of TRP Channels in DPN | 临床试验